Suppression of high rate pacing for reducing myocardial ischemic irritability
US7881786B2 · kind B2 · utility
82Cited by
22References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 29, 2005 |
| Grant date | Feb 1, 2011 |
| Priority date | — |
| Expiry date | May 16, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/3702
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A medical device capable of delivering automatic rate-adjusting pacing therapies is provided having an adjustable upper rate limit responsive to an indication of myocardial irritability. The device, which may be embodied as a pacemaker, a pacemaker/cardioverter/defibrillator, or the like, responds to the detection of an arrhythmia as an indicator of myocardial irritability by adjusting an upper rate limit. The adjusted upper rate limit is applied as the maximum allowable pacing rate during delivery of any pacing therapies previously defined as “long-term” pacing therapies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.